Get a quote

We're excited to learn more about your project and provide you with a customized quote tailored to your needs. Please fill out the form below, and we'll get back to you as soon as possible.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Rabbit Anti-Shigella Polyclonal Antibody [Biotin]

Cat. No.VD11Y662

Product TypeVeterinary Antibodies

Size

Product Overview

BioVenic rabbit monoclonal antibody is specific for the Shigella. It can be applied to ELISA and IF to help researchers detect or develop diagnosis assays of Shigella infection.

Specifications

Application IF; ELISA
Clonality Polyclonal Antibody
Classification Primary Antibody
Clone N29Y102
Host Rabbit
Target Species Bacteria
Species Reactivity Bacteria
Specificity Shigella
Isotype IgG
Immunogen Inactive whole-cell Shigella.
Conjugation Biotin
Preservative and Stabilizer 0.1% Sodium azide (NaN3)
Buffer 1X Phosphate buffered saline, pH 7.2
Physical State Liquid

Target Information

Shigella is a genus of bacteria that includes several species capable of causing gastrointestinal infections in animals and humans. The infections caused by Shigella are collectively referred to as shigellosis, and they are characterized by symptoms such as diarrhea, abdominal cramps, fever, and sometimes bloody stools. Shigella is highly contagious and is primarily transmitted through the fecal-oral route, often in conditions of poor hygiene and contaminated food or water.

Target Shigella
Taxonomy ID 620

Shipping and Storage

This product is shipped with dry ice. Store at -20°C on receipt (up to 12 months). Avoid repeated freezing and thawing as this may denature the antibody.

Documents

COA

To request a Certificate of Analysis, please enter the Lot No. in the search box. Note: Certificate of Analysis not available for kits.

The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.

References

  1. Mani, Sachin, et al. "Status of vaccine research and development for Shigella." Vaccine 34.26 (2016): 2887-2894.
Inquiry Basket